Company attributes
Investor attributes
Other attributes
Takeda Pharmaceutical Company is a company that provides research-based healthcare and medical products. The company was founded by Chobei Takeda I in 1781, in Osaka, Osaka, Japan.
The company is primarily patient-focused, research and development driven, and is interested in biopharmaceuticals. The company operates in the United States with 18,000 employees. The company looks to develop pharmaceutical products and conduct corporate citizenship activities.
COVID-19
Takeda Pharmaceutical Company has announced a plan of action in response to COVID-19. Their plan since the outbreak of the virus is to develop a plasma-derived therapy; an anti-SARS-CoV-2 polyclonal-hyper-immune-globuli that is designed specifically for high risk patients.
The company's therapy includes concentrated pathogen-specific antibodies that are derived from plasma of recovered patients. Takeda Pharmaceuticals Company believes the antibodies have the potential to generate an immune response when injected into a new patient.
